|
|
Barbara Rehermann
J Clin Invest. 2009;
119(7):1745
doi:10.1172/JCI39133
Abstract |
Full text
| PDF
| Supplemental material
S
ince the identification of the hepatitis C virus (HCV) 20 years ago, much progress has been made in our understanding of its life cycle and interaction with the host immune system. Much has been learned from HCV itself, which, via decades of coevolution, gained an intricate knowledge of host innate and adaptive immune responses and developed sophisticated ways to preempt, subvert, and antagonize them. This review discusses the clinical, virological, and immunological features of acute and chronic hepatitis C and the role of the immune response in spontaneous and treatment-induced HCV clearance.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(80)
| Title and authors |
Publication |
Year |
Discrimination of agonist and antagonist forms of CXCL10 in biological samples : Discriminating agonist and antagonist CXCL10
A. Casrouge, A. Bisiaux, L. Stephen, M. Schmolz, J. Mapes, C. Pfister, S. Pol, V. Mallet, M. L. Albert
|
Clinical & Experimental Immunology
|
2012 |
Treatment of chronic hepatitis C - are interferons really necessary?
Peter Ferenci
|
Liver International
|
2012 |
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
J. Schulze zur Wiesch, D. Ciuffreda, L. Lewis-Ximenez, V. Kasprowicz, B. E. Nolan, H. Streeck, J. Aneja, L. L. Reyor, T. M. Allen, A. W. Lohse
|
Journal of Experimental Medicine
|
2012 |
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Robert Thimme, Marco Binder, Ralf Bartenschlager
|
FEMS Microbiology Reviews
|
2012 |
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion
H. Park, W. O. Osburn, E. Winkelstein, S. Raghuraman, B. R. Edlin, B. Rehermann
|
J. Infect. Dis.
|
2012 |
Recurrent Viral Diseases after Liver Transplantation
Jennifer C. Lai, Norah A. Terrault
|
Zakim and Boyer s Hepatology
|
2012 |
The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling : RIBA-INDETERMINATE REACTIVITY
Sukanya Raghuraman, Peter D. Burbelo, Cathy C. Cantilena, Addisalem T. Makuria, Robert D. Allison, Joan Gibble, Barbara Rehermann, Harvey J. Alter
|
Transfusion
|
2012 |
Differential Antigen Specificity of Hepatitis C Virus-Specific Interleukin 17- and Interferon -Producing CD8+ T Cells During Chronic Infection
S. Grafmueller, E. Billerbeck, H. E. Blum, C. Neumann-Haefelin, R. Thimme
|
J. Infect. Dis.
|
2012 |
Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection
Pothakamuri Venkata Suneetha, Sven Pischke, Verena Schlaphoff, Jan Grabowski, Paraskevi Fytili, Anna Gronert, Birgit Bremer, Antoaneta Markova, Jerzy Jaroszewicz, Christoph Bara
|
Hepatology
|
2012 |
Up-regulation of FOXP3 and induction of suppressive function in CD4<sup>+</sup> Jurkat T-cells expressing hepatitis C virus core protein
Margarita Dominguez‑Villar, Cecilia Fernandez‑Ponce, Alba Munoz‑Suano, Esperanza Gomez, Manuel Rodríguez‑Iglesias, Francisco Garcia‑Cozar
|
Clin. Sci.
|
2012 |
|
